Revolution IP, PLLC
Anti-inflammatory composition
The present invention relates to an anti-inflammatory composition, and more particularly to an anti-inflammatory composition containing, as an active ingredient, a compound represented by Formula 1 or a salt thereof, wherein the anti-inflammatory composition may inhibit inflammatory response even at an early stage by inhibiting the interaction between CD14 and LPS and blocking the expression of CD14 and the expression of TNFα and IL-1β, which are the key factors in inflammatory response, and may also regulate the expression of important factors, such as CCL2 (MCP-1), CCL7 (MCP-3), CXCL2, CHOP and NOX1, which are involved in inflammatory response.
OSTEONEUROGEN INC.
A A
A61P A61K
inventional inventional
Min Ju Baik Lin Han Soo Moon Kee Ik Hwan Ho Sup Byung Soo Hyeong Deok
Ham Seong Kim Maeng Kim Yoon Youn Choi